EyeGene Inc. (KOSDAQ:185490)
South Korea · Delayed Price · Currency is KRW 1,720.00
+28.00 (1.65%)
At close: Nov 6, 2026
EyeGene Market Cap
EyeGene has a market cap or net worth of 74.36 billion as of November 5, 2026. It is the 29,164th most valuable company in the world and the 1,429th biggest in South Korea. Its market cap has increased by 52.57% in one year.
Market Cap
74.36B
Enterprise Value
35.23B
Revenue
4.48B
Global Rank
Country Rank
#1,429 South Korea
PE Ratio
n/a
ChartMarket Cap Chart
Since November 16, 2015, EyeGene's market cap has decreased from 131.00B to 74.36B, a decrease of -43.24%. That is a compound annual growth rate of -5.03%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 6, 2026 | 74.36B | -1.09% |
| Dec 30, 2025 | 75.18B | 8.64% |
| Dec 30, 2024 | 69.20B | -24.46% |
| Dec 28, 2023 | 91.61B | -15.21% |
| Dec 29, 2022 | 108.04B | -73.58% |
| Dec 30, 2021 | 408.92B | 175.32% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| AriBioLab | 93.57B |
| ViGenCell | 91.63B |
| Prestige Biologics | 90.89B |
| Choong Ang Vaccine Laboratory | 82.85B |
| CHOOLIP & SCIENCES | 81.18B |
| BIO-FD&C | 78.70B |
| CORESTEMCHEMON | 70.84B |
| Naturalendo Tech | 65.99B |